Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

BK Psykiater ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.6% 0.6%   Bankruptcy risk   8.5% 6.5% 11.5% 7.6% 7.0% 5.7% 18.4% 18.1%   Credit score (0-100)   30 38 21 31 34 39 8 8   Credit rating   BB BBB BB BB BBB BBB B B   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,584 1,837 1,903 2,149 2,652 2,589 0.0 0.0   EBITDA   -103 169 -188 61.6 236 172 0.0 0.0   EBIT   -251 132 -224 24.7 236 101 0.0 0.0   Pre-tax profit (PTP)   -254.0 131.4 -224.5 20.7 233.7 66.0 0.0 0.0   Net earnings   -220.7 102.4 -175.1 15.6 182.3 49.6 0.0 0.0   Pre-tax profit without non-rec. items   -254 131 -224 20.7 234 66.0 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   113 76.3 39.4 2.5 2.5 478 0.0 0.0   Shareholders equity total   144 246 71.3 86.9 269 239 129 129   Interest-bearing liabilities   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   316 416 426 425 550 852 129 129   Net Debt   -161 -320 -301 -353 -529 -362 -129 -129     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,584 1,837 1,903 2,149 2,652 2,589 0.0 0.0   Gross profit growth   79.6% 16.0% 3.6% 12.9% 23.4% -2.4% -100.0% 0.0%   Employees   1 1 1 1 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   316 416 426 425 550 852 129 129   Balance sheet change%   -50.6% 31.7% 2.5% -0.3% 29.5% 54.9% -84.9% 0.0%   Added value   -102.6 169.0 -187.5 61.6 272.5 171.6 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -302 -74 -74 -74 0 405 -478 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -1.0 1.0 -1.0 1.0 2.0 3.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   -15.8% 7.2% -11.8% 1.2% 8.9% 3.9% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   -52.6% 36.1% -53.3% 5.8% 48.3% 14.4% 0.0% 0.0%   ROI %   -87.6% 67.7% -141.3% 31.2% 132.3% 39.1% 0.0% 0.0%   ROE %   -79.0% 52.4% -110.2% 19.7% 102.4% 19.5% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   45.6% 59.2% 16.7% 20.5% 48.9% 28.0% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   157.4% -189.0% 160.7% -572.5% -224.3% -210.9% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   1.1 1.9 1.1 1.2 1.9 0.6 0.0 0.0   Current Ratio   1.1 1.9 1.1 1.2 1.9 0.6 0.0 0.0   Cash and cash equivalent   161.5 319.6 301.4 352.6 528.6 361.9 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   18.9 158.2 19.9 72.4 254.7 -242.3 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   -103 169 -188 62 273 172 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   -103 169 -188 62 236 172 0 0   EBIT / employee   -251 132 -224 25 236 101 0 0   Net earnings / employee   -221 102 -175 16 182 50 0 0